Clinitech Laboratory IPO listing price is ₹ 120.75, issue price is ₹ 96.00, and currently trading at ₹ 37.15 as on June 11, 2025. Clinitech Laboratory IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Clinitech Laboratory IPO is a Fixed Price listing on BSE SME exchange. The company is based in Mumbai and caters to Healthcare sector. Inventure Merchant Banker Services is the merchant banker of Clinitech Laboratory IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 23rd January 2024.
Clinitech Laboratory IPO offer price is ₹ 96.00 and got listed at ₹ 120.75. Read Clinitech Laboratory IPO details mentioned above.The IPO of Clinitech Laboratory Limited was listed on 1st August 2024. As of today, Clinitech Laboratory IPO is trading at ₹ 37.15, compared to the previous day’s close of ₹ 36.06. Read the report above for detailed IPO performance.
The issue price of Clinitech Laboratory IPO was ₹ 96.00 per equity share.
Clinitech Laboratory IPO was listed at ₹120.75 on the stock exchange on 1st August 2024. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of June 11, 2025, the current market price of Clinitech Laboratory IPO is ₹ 37.15.
The 52-week high for Clinitech Laboratory IPO is [●], while the 52-week low is ₹ 36.02. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Clinitech Laboratory IPO listed at ₹ 120.75 against the issue price of ₹ 96.00 per equity share, showing a listing day gain/loss of 24.75 (25.78%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Clinitech Laboratory IPO stock moved from its listing price of ₹ 120.75 to the current price of ₹37.15 per equity share, reflecting a change of -69.23% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Clinitech Laboratory IPO issue date of 1st August 2024 and CMP of ₹37.15, the estimated CAGR is approximately -66.37%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Clinitech Laboratory IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Clinitech Laboratory Financial Review Page
Merchant Banker(s) of Clinitech Laboratory IPO: Inventure Merchant Banker Services Private Limited
Clinitech Laboratory IPO subscription was 38.96 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Clinitech Laboratory IPO listed at a listing price of 120.75 against the offer price of 96.00.
The current market price of Clinitech Laboratory is 37.15.
Why Us?